US stroke legislation is revised after BMJ airs controversy.
Lenzer
Jeanne
J
D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006782:Hospitals, Special / Q000331:legislation & jurisprudence*; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014481:United States
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator